Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Mar;47(3):263–265. doi: 10.1136/jcp.47.3.263

CA 125 secretion by peritoneal mesothelial cells.

A M Zeillemaker 1, H A Verbrugh 1, A A Hoynck van Papendrecht 1, P Leguit 1
PMCID: PMC501908  PMID: 8163699

Abstract

AIMS--To investigate the secretion of the tumour marker CA 125 by cultured human mesothelial cells; to determine if secretion of CA 125 could be observed by activating the mesothelial monolayers with different cytokines. METHODS--Mesothelial cells were isolated from human omentum and cultured to confluent monolayers on perforated polycarbonate membranes (pore size 0.4 micron). The mesothelial monolayers were activated and the apical and basolateral secretion of CA 125 compared. To investigate the influence of cytokines, mesothelial cells were cultured and activated with recombinant interleukin-1 beta (rIL-1 beta), tumour necrosis factor-alpha (TNF-alpha) or lipopolysaccharide from Escherichia coli. The secretion of CA 125 was tested using a microparticle enzyme immunoassay. RESULTS--Mesothelial monolayers secreted CA 125 in a polarised manner with preference for the apical side. Apical polarisation occurred irrespective of the side of the inducing stimulus (p < or = 0.05). Non-activated cultured mesothelial monolayers secreted significant quantities of CA 125, indicating constitutive production of this protein. However, CA 125 production was significantly enhanced if mesothelial cells were incubated with rIL-1 beta (p < or = 0.05), TNF-alpha (p < or = 0.05), and E coli LPS (p < or = 0.01). CONCLUSIONS--Human mesothelial monolayers secrete CA 125 preferentially from their apical surfaces. The secretion of CA 125 can be enhanced by the inflammatory cytokines Il-1 beta, TNF-alpha, and by E coli LPS.

Full text

PDF
263

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baggiolini M., Walz A., Kunkel S. L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989 Oct;84(4):1045–1049. doi: 10.1172/JCI114265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bast R. C., Jr, Feeney M., Lazarus H., Nadler L. M., Colvin R. B., Knapp R. C. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981 Nov;68(5):1331–1337. doi: 10.1172/JCI110380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bast R. C., Jr, Klug T. L., St John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13;309(15):883–887. doi: 10.1056/NEJM198310133091503. [DOI] [PubMed] [Google Scholar]
  4. Bergmann J. F., Bidart J. M., George M., Beaugrand M., Levy V. G., Bohuon C. Elevation of CA 125 in patients with benign and malignant ascites. Cancer. 1987 Jan 15;59(2):213–217. doi: 10.1002/1097-0142(19870115)59:2<213::aid-cncr2820590206>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  5. Canney P. A., Moore M., Wilkinson P. M., James R. D. Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. Br J Cancer. 1984 Dec;50(6):765–769. doi: 10.1038/bjc.1984.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Connell N. D., Rheinwald J. G. Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell. 1983 Aug;34(1):245–253. doi: 10.1016/0092-8674(83)90155-1. [DOI] [PubMed] [Google Scholar]
  7. Dobbie J. W. New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis. Am J Kidney Dis. 1990 Feb;15(2):97–109. doi: 10.1016/s0272-6386(12)80506-3. [DOI] [PubMed] [Google Scholar]
  8. Einhorn N., Bast R. C., Jr, Knapp R. C., Tjernberg B., Zurawski V. R., Jr Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer. Obstet Gynecol. 1986 Mar;67(3):414–416. [PubMed] [Google Scholar]
  9. Fleuren G. J., Nap M., Aalders J. G., Trimbos J. B., de Bruijn H. W. Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors. Cancer. 1987 Nov 15;60(10):2437–2442. doi: 10.1002/1097-0142(19871115)60:10<2437::aid-cncr2820601015>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  10. Halila H., Stenman U. H., Seppälä M. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer. 1986 Apr 1;57(7):1327–1329. doi: 10.1002/1097-0142(19860401)57:7<1327::aid-cncr2820570713>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  11. Hunter V. J., Weinberg J. B., Haney A. F., Soper J. T., Lavin P., Metsch L., Knapp R. C., Bast R. C., Jr CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer. Gynecol Oncol. 1990 Feb;36(2):161–165. doi: 10.1016/0090-8258(90)90165-h. [DOI] [PubMed] [Google Scholar]
  12. Kabawat S. E., Bast R. C., Jr, Bhan A. K., Welch W. R., Knapp R. C., Colvin R. B. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol. 1983;2(3):275–285. doi: 10.1097/00004347-198303000-00005. [DOI] [PubMed] [Google Scholar]
  13. Lehtovirta P., Apter D., Stenman U. H. Serum CA 125 levels during the menstrual cycle. Br J Obstet Gynaecol. 1990 Oct;97(10):930–933. doi: 10.1111/j.1471-0528.1990.tb02449.x. [DOI] [PubMed] [Google Scholar]
  14. Molina R., Filella X., Bruix J., Mengual P., Bosch J., Calvet X., Jo J., Ballesta A. M. Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem. 1991 Aug;37(8):1379–1383. [PubMed] [Google Scholar]
  15. Okazaki K., Mizuno K., Katoh K., Hashimoto S., Fukuchi S. Tuberculous peritonitis with extraordinarily high serum CA125. J Med. 1992;23(5):353–361. [PubMed] [Google Scholar]
  16. Talbot R. W., Jacobsen D. J., Nagorney D. M., Malkasian G. D., Ritts R. E., Jr Temporary elevation of CA 125 after abdominal surgical treatment for benign disease and cancer. Surg Gynecol Obstet. 1989 May;168(5):407–412. [PubMed] [Google Scholar]
  17. Wu Y. J., Parker L. M., Binder N. E., Beckett M. A., Sinard J. H., Griffiths C. T., Rheinwald J. G. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell. 1982 Dec;31(3 Pt 2):693–703. doi: 10.1016/0092-8674(82)90324-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES